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Retinoic acid is clearly important for the development of the heart. In this paper, we provide evidence that retinoic acid is essential for multiple
aspects of cardiogenesis in Xenopus by examining embryos that have been exposed to retinoic acid receptor antagonists. Early in cardiogenesis,
retinoic acid alters the expression of key genes in the lateral plate mesoderm including Nkx2.5 and HAND1, indicating that early patterning of the
lateral plate mesoderm is, in part, controlled by retinoic acid. We found that, in Xenopus, the transition of the heart from a sheet of cells to a tube
required retinoic acid signaling. The requirement for retinoic acid signaling was determined to take place during a narrow window of time between
embryonic stages 14 and 18, well before heart tube closure. At the highest doses used, the lateral fields of myocardium fail to fuse, intermediate
doses lead to a fusion of the two sides but failure to form a tube, and embryos exposed to lower concentrations of antagonist form a heart tube that
failed to complete all the landmark changes that characterize looping. The myocardial phenotypes observed when exposed to the retinoic acid
antagonist resemble the myocardium from earlier stages of cardiogenesis, although precocious expression of cardiac differentiation markers was
not seen. The morphology of individual cells within the myocardium appeared immature, closely resembling the shape and size of cells at earlier
stages of development. However, the failures in morphogenesis are not merely a slowing of development because, even when allowed to develop
through stage 40, the heart tubes did not close when embryos were exposed to high levels of antagonist. Indeed, some aspects of left–right
asymmetry also remained even in hearts that never formed a tube. These results demonstrate that components of the retinoic acid signaling
pathway are necessary for the progression of cardiac morphogenesis in Xenopus.
© 2005 Elsevier Inc. All rights reserved.Keywords: Cardiogenesis; Xenopus; Retinoic acid; Nkx2.5; GATA-4; Cardiac troponin I; Heart development; Retinoic acid antagonist; Left–right asymmetryIntroduction
Primarily because of its ease of manipulation and ability to
survive with a severely compromised heart, Xenopus has
emerged as an excellent model for looking at inductive inter-
actions in early cardiogenesis (Mohun et al., 2003). In Xenopus,
the heart is specified during gastrulation as a result of signals
emanating from Spemann's organizer and from the deep endo-⁎ Corresponding author. Department of Paediatrics, University of Western
Ontario, Canada. Fax: +1 519 685 8186.
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doi:10.1016/j.ydbio.2005.12.018derm (Nascone and Mercola, 1995; Sater and Jacobson, 1989;
Schneider and Mercola, 1999). After specification, the heart is
located on either side of Spemann's organizer as two bilateral
patches. These patches subsequently migrate and fuse at the
ventral midline, just caudal to the cement gland. Once fused,
the lateral edges of the sheet of cells pinch together to form a
linear heart tube (Raffin et al., 2000). The heart tube then
undergoes its characteristic dextral looping and further complex
morphogenetic movements that result in the final three-cham-
bered heart of Xenopus (Kolker et al., 2000; Mohun et al.,
2000). Interplay between multiple signaling systems is required
for specification and patterning of the heart, including the wnt
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2002; Schneider and Mercola, 2001), fibroblast growth factor
signaling (Alsan and Schultheiss, 2002), bone morphogenetic
protein signaling (Breckenridge et al., 2001), and the Notch
signaling pathway (Rones et al., 2000).
Retinoic acid (RA) is also critical in the patterning and
development of the heart. RA, the active form of vitamin A,
binds to RA receptors (RARα, β, and γ) and their heterodi-
meric partner, members of the retinoid X receptor family
(RXRα, β, and γ). This complex acts as a ligand-activated
transcription factor, binding to retinoic acid response elements
(RAREs) of target genes, and it is essential for many aspects of
embryonic development (Glass and Rosenfeld, 2000; Ross et
al., 2000; Zile, 2001). In the embryonic heart, RA signaling is
primarily mediated through the RARα receptor with a minor
component of the signal coming through the RARβ receptor
(Kastner et al., 1997). The enzyme primarily responsible for
RA synthesis, retinaldeyde dehydrogenase 2 (RALDH2), is
expressed adjacent to the developing sino-atrial region during
early cardiogenesis (Chen et al., 2001; Hochgreb et al., 2003;
Xavier-Neto et al., 1999), suggesting that a gradient of RA may
be generated along the anterior–posterior axis of the heart tube.
Embryos that have had RA signaling attenuated have a
variety of cardiac phenotypes indicating multiple roles for
RA in cardiogenesis. In zebrafish, embryos that lack RA
signaling have an excess of cardiomyocytes indicating that
RA limits the pool of cardiac progenitors in the cardiac form-
ing region (Keegan et al., 2005). Loss of function experiments
in mammalian embryos created by genetic ablation of RA
receptors or RALDH2 (Niederreither et al., 2001) have
shown that RA is necessary for normal cardiac morphogenesis
and anterior–posterior patterning of the heart tube (Hochgreb
et al., 2003; Iulianella and Lohnes, 2002; Kastner et al., 1997;
Sucov et al., 1994). Early developmental defects resulting
from reduced RA signaling include abnormal cardiac looping,
altered sino-atrial development, and prematurely differentiated
ventricular cardiomyocytes (Hochgreb et al., 2003; Nieder-
reither et al., 2001). Exclusion of RA from the ventricle region
is essential for formation of this region in early cardiogenesis
(Rosenthal and Xavier-Neto, 2000; Xavier-Neto et al., 2001).
In chick, loss of function experiments using dietary deficiency
and by the use of RA antagonists have demonstrated anterior–
posterior defects and disrupted heart looping (Chazaud et al.,
1999; Ghatpande et al., 2000; Hochgreb et al., 2003; Kostets-
kii et al., 1999; Tsukui et al., 1999). During later stages of
cardiogenesis, RA is generated by the epicardium and is im-
portant in stimulating proliferation of the ventricular myocar-
dium (Chen et al., 2002; Munoz-Chapuli et al., 2002;
Stuckmann et al., 2003; Xavier-Neto et al., 2000).
Several key questions remain concerning the role of RA in
cardiogenesis. First, do the variety of roles ascribed to RA
represent a common underlying theme such as axis formation
or modulation of differentiation? Secondly, if the sites of syn-
thesis and degradation of RA are arranged in such a manner that
a graded level of RA should be seen in the heart, why does a
global application of RA rescue cardiac defects in various
models of RA insufficiency (Xavier-Neto et al., 2001)? A betterunderstanding of the phylogenetic differences in cardiogenesis,
and the role of RA signaling in the process, will help elucidate
underlying mechanisms in heart development (Xavier-Neto et
al., 2001).
To this end, we have endeavored to clarify the role of RA
signaling in Xenopus cardiogenesis. As in other model systems,
RALDH2 is expressed near the sino-atrial region of the devel-
oping heart, and Cyp26, the enzyme primarily responsible for
RA degradation, is expressed in a non-overlapping, comple-
mentary pattern (Haselbeck et al., 1999; Hollemann et al.,
1998). Xenopus embryos exposed to excess RA prior to cardiac
differentiation have a presumptive myocardium with reduced
levels of Nkx2.5 and increased levels of GATA-4, -5, and -6
(Jiang et al., 1999). This treatment can result in a complete
block to myocardial differentiation as assayed by cardiac tro-
ponin I (cTnI) expression (Drysdale et al., 1997). Although
these gain of function experiments indicate that levels of RA
signaling may also be important in amphibian cardiogenesis,
these gain of function experiments do not define the normal
role for RA signaling in Xenopus cardiogenesis.
Through the use RA antagonists (Teng et al., 1997), we
demonstrate for the first time that the RA signaling pathway
is essential, during a restricted window of time after gastrula-
tion, for early events in cardiac morphogenesis in Xenopus. The
primary defect is an inability to form a heart tube from the
original sheet of cells. At lower concentrations of the antago-
nist, cardiac morphogenesis proceeds further but is still blocked
before normal morphogenesis is completed. If embryos are
treated with RA antagonist prior to gastrulation, the Nkx2.5
expression domain is expanded, as observed in zebrafish (Kee-
gan et al., 2005), but this initial increase in the size of the
cardiac domain is not sustained. Despite the altered appearance
of the myocardium, we do not find that reduced RA signaling
leads to premature differentiation of the myocardium contrast-
ing observations in mice, although the myocardium remains
immature in appearance. We also demonstrate that the myocar-
dium still has some of the characteristics of left–right asymme-
try, although many of the characteristic shape changes that
occur during looping were clearly absent. Thus, we provide
evidence that stage-specific RA signaling is critical for com-
pletion of the cardiac development in Xenopus.
Materials and methods
Embryo collection
Female Xenopus laevis frogs were injected with 600–700 IU of human
chorionic gonadotrophin (Sigma) to induce ovulation. In vitro fertilization of
ovulated eggs was performed in 80% Steinberg's solution containing minced
testis. Embryos were dejellied with 2.5% cysteine, pH 8.0, and cultured in 20%
Steinberg's solution. Embryos were staged according to Nieuwkoop and Faber
(1994).
Experimental treatments
Experimental treatments included exposure to 1 μM all-trans retinoic acid
(RA, Sigma), 1 μM retinoic acid receptor α agonist (Allergan #193836, Teng et
al., 1996), pan-retinoic acid receptor antagonist (Allergan #193109, Johnson et
al., 1995), and 1 μM retinoic acid receptor α antagonist (Allergan #194301,
Fig. 1. Blocking retinoic acid signaling at stage 12/14 results in a failure to form
a simple heart tube. Whole-mount in situ hybridization for cTnI was used to
visualize the differentiated myocardium (blue staining). In stage 31 embryos, a
normal linear heart tube that is just starting to loop (A). The tube and looping
are best viewed from the ventral side of the embryo (B). When embryos are
treated with 1 μM RA, the heart is severely disrupted (C), although when
viewed from the ventral side, it can be seen that a tube is still formed (D).
When treated with 1 μM AGN 194301, myocardial differentiation still occurs
(E), but when viewed from the ventral side, the lack of tube formation is clear
(F). Addition of equimolar (1 μM) concentrations of both RA and AGN 194301
resulted in an apparently normal heart tube indicating that the observed effects
are not due to toxicity of the compounds used (G, H).
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solutions in 100% ethanol or DMSO; as a result, the control treatment was 0.1%
ethanol or DMSO in 20% Steinberg's. Treatments were done by immersion and
were continuous until the embryos were fixed for in situ hybridization or
confocal microscopy.
In experiments which determine the timing of differentiation events, batches
of embryos were treated with either 1 μM AGN 194301 or 1 μM RA and
embryos from each batch were assayed for cardiac differentiation by whole-
mount in situ hybridization for cTnI or αMHC mRNA.
Whole-mount in situ hybridization and histology
Whole-mount in situ hybridization was performed according to Harland
(1991) with modifications by Drysdale et al. (1997). In addition, embryos were
blocked using a maleic acid buffer (pH 7.5), 2% Boehringer Mannheim block-
ing reagent, and 4% heat-treated lamb serum solution and washed in maleic acid
buffer. Antisense riboprobes for Nkx2.5 (Tonissen et al., 1994), GATA-4 (Kelley
et al., 1993), cTnI (Drysdale et al., 1994), and αMHC (Logan and Mohun,
1993) were labeled with dioxygenin-UTP (Roche Diagnostics) according to
Harland (1991) except that 32P-labeled nucleotides were not incorporated into
the probes. Probes were re-suspended directly in RNA hybridization buffer
without alkaline hydrolysis. Once the color reaction was complete, using
NBT/BCIP or BM Purple (Roche Diagnostics), embryos were fixed overnight
in Bouin's fixative, and endogenous pigment was bleached out under fluores-
cent light, using a solution containing 1% hydrogen peroxide, 5% formamide,
and 0.5× SSC, for several hours. To better see internal structures, some embryos
were cleared in 1 benzyl alcohol:2 benzyl benzoate. Embryos were photo-
graphed using a Leica MZ12 dissecting microscope and Northern Eclipse
software (Empix Imaging).
For sections, embryos were fixed according to the whole-mount procedure
but were then re-hydrated after storage in methanol in a methanol series, rinsed
in PBS, and incubated in 15% sucrose in PBS. Embryos were then placed in
embedding solution (15% sucrose, 7.5% gelatin in PBS) overnight. Embryos
were then frozen on dry ice and sectioned on a Leica CM1900 cryostat micro-
tome. Cryostat sections of embryos were cut at 15 μm. In situ hybridization on
the slide was then done using standard procedures (Jensen and Wallace, 1997).
Heart rate analysis
Heart rate was calculated based on the number of heart contractions in a 10 s
period, with 40 individual embryos measured for each treatment. Measurements
of beating heart rate are presented as mean ± SEM in beats/minute. Statistical
significance differences were calculated using a student's t test. Significance
was accepted at the level of P b 0.01.
Confocal microscopy
Tadpoles were fixed in Dent's Fixative (80% methanol, 20% dimethyl
sulfoxide (DMSO)) and stored at −20°C until processed. Except where noted,
subsequent treatments and rinses were carried out on samples in 24-well plates
on an orbital shaker. Prior to immunolabeling, the ventral dermal layer over-
lying the hearts was manually removed to help antibody penetration and ensure
optimal imaging of the hearts. Embryos were rehydrated to PBS in a methanol–
PBS series which included 1% DMSO at each step and blocked for 4 h at room
temperature or overnight at 4°C in PBS–TD blocking solution (PBS, 1% Tween
20, 1% DMSO, 0.02% NaN3) containing 0.1 M glycine, 2% powdered milk,
and 1% BSA. Primary antibodies were diluted with block solution. The cardiac
troponin I antibody, purchased from Fitzgerald, was diluted 1:500; the flectin
(F-22) antibody, a gift from Nancy Philp (Thomas Jefferson University), was
used at 1:40. Incubation with primary antibody was carried out overnight at
4°C. Samples were then rinsed six to eight times over 8–10 h with PBS–TD.
Secondary antibodies were used as follows: anti-goat conjugated to Alexa 568,
anti-mouse IgG conjugated to Cy5 (both from Jackson Immunoresearch). Both
were diluted 1:200 in blocking solution and allowed to incubate with the sample
overnight at 4°C. Samples were rinsed as described for primary antibody
treatment and subsequently dehydrated in an ethanol series. Embryos were
mounted for viewing as described in Kolker et al. (2000).Results
Retinoic acid signaling is required for formation of the heart
tube
By stage 30/32, the Xenopus heart has differentiated, as
detected by expression of cTnI or αMHC (Figs. 1A, B). As
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1997; Jiang et al., 1999), continuous treatment with 1 μM all-
trans RA from stage 12 until stage 30/32 resulted in either a
marked inhibition or complete elimination of cTnI expression
(Figs. 1C, D). In these assays, cTnI expression is used as an
indicator of myocardial differentiation. The region of cTnI
expression was markedly reduced, when present, and located
in a more anterior position than in control embryos. Despite the
substantial reduction in size, heart tube closure is observed
(Figs. 1C, D).
We contrast the changes above with those resulting from
treatment with 1 μM RA antagonist (AGN 194301). Embryos
treated with the antagonist starting at stage 12/14 displayed a
moderate inhibition of the cTnI expression domain. However,
the expression domain that remained was very different from
the cTnI expression domain in either control embryos or those
treated with RA. While the RA-treated embryos retained the
anterior expression of cTnI, embryos treated with AGN
194301 retained expression at the posterior end of the normal
heart-forming region (Figs. 1E, F). The hearts in these embry-
os never formed a tube. Instead, the myocardium appeared as
a sheet of cells on the ventral side of the embryo. Furthermore,
in embryos treated with 1 μM AGN 194301, the cTnI expres-
sion domain is often split with an apparent failure to meet
properly along the ventral midline, retaining a more lateral
position. These changes in cardiac morphology were not due
to toxic effects as adding both 1 μM RA and 1 μM AGN
194301 to embryo cultures largely restored normal cardiac
development (Figs. 1G, H).
As AGN 194301 is an RARα antagonist, it is possible that
blocking this specific receptor may cause increased signaling to
the other RAR family members, although at a concentration of
1 μM, AGN 194301 will likely inhibit other RARs. To elimi-
nate this possibility, we also treated embryos with AGN
194109, a pan RAR antagonist (Johnson et al., 1995). We
could not detect any differences in phenotype between embryos
treated with AGN 194301 and AGN 194109-treated embryos
when used at similar concentrations and times. Thus, we con-
clude that the observed phenotype when adding AGN 194301
is due to an attenuation of RA signaling.
Addition of the RA antagonist, AGN 194301, at stage 12/14
resulted in few obvious morphological changes to the rest of the
embryo. A modest increase in the size of the head and the
cement gland was observed (Fig. 1E), and the embryos
appeared to lack lymph hearts, a small beating organ found
near the developing kidney (data not shown), which had previ-
ously been shown to increase in size as a result of RA treatment
(Drysdale et al., 1994).
Embryos continuously treated with AGN 194301, from
stage 14 onwards, were sectioned and stained over the length
of the developing heart. The failure to form a tube is seen along
the entire length of the heart tube. The degree of heart tube
formation was concentration-dependent (Fig. 2). At 1 μMAGN
194301, there was no evidence of any movements towards
generating a tube (Figs. 2B, F, J, N, R). In embryos that were
treated with 100 nM AGN 194301 (Figs. 2C, G, K, O, S), the
two sides of the patches did appear to be, at least superficially,trying to form a tube. At the 10 nM AGN 194301 dose, there
was partial closure of the heart tube (Fig. 2L), but, at stage 32/
34, the heart tube still did not appear to have undergone any
looping morphogenesis.
The effects of AGN 194301 on heart formation were best
visualized by looking on the ventral side of embryos (Stage
32/34) after in situ hybridization for cTnI (Fig. 3). At high
concentrations (1 μM), AGN 194301 treatment resulted in the
appearance of gaps at the ventral midline with the two patches
of cardiac tissue on either side of the gap (Fig. 3B). If left to
develop, the embryos only exhibit a single beating mass of
tissue, so the presence of the gap did not result in obvious
cardia bifida. At concentrations as low as 10 nM AGN
194301, there were still embryos where the heart remained
as a ventral sheet (Fig. 3C). If the sheet was able to curl into a
tube, the tube still appeared linear, indicating that looping of
the heart tube was either impaired or delayed (contrast Figs.
3A and D). A summary of the cardiac morphological defects
resulting from differing concentrations of AGN 194301 is
listed in Table 1.
Mice that are deficient in RA signaling show premature
differentiation of ventricular myocytes (Kastner et al., 1997;
Niederreither et al., 2001). This could potentially explain the
phenotypes observed when blocking RA synthesis. If myocar-
dial differentiation was occurring early in Xenopus embryos
treated with AGN 194301, then one might expect incomplete
morphogenesis. To test if premature differentiation was occur-
ring in our embryos, we assessed the timing of initial cTnI
expression as an indicator of differentiation. In untreated em-
bryos, cTnI is first expressed between stages 26 and 28. We
found that in embryos treated with AGN 194301 did not ex-
press cTnI any earlier than control embryos, indicating that they
were not differentiating prematurely (Table 2).
The retinoic acid signaling pathway is required between stage
14 and 18
We found that embryos continuously treated with AGN
194301, starting at stage 14, failed to form a heart tube. If the
AGN 194301 treatment was initiated later than stage 16, a tube
is formed, although other morphological defects were still
observed. If both RA and AGN 194301 were added at the
same time, heart tube formation was rescued (Figs. 4D, J), as
it was if the addition of RA was delayed until stage 16 (Figs.
4E, K). However, if addition of RAwas delayed until stage 18/
20, a time of approximately 4 h at room temperature, formation
of the tube was impaired (Figs. 4F, L). In all cases, embryos
were allowed to develop until stage 31/32 where the degree of
heart tube formation was assessed.
The expression patterns of Nkx2.5 and GATA-4 are altered by a
lack of retinoid signaling
Nkx2.5 and GATA-4 are both key transcription factors in
cardiac development and are known to be altered by addition
of RA (Jiang et al., 1999). It was therefore hypothesized that
AGN 194301 treatment would also alter the expression
Fig. 2. Dose-dependent defects in cardiac morphogenesis caused by the retinoic acid antagonist. To better visualize the defects in cardiac morphogenesis due to
addition of antagonist, αMHC expression was examined in serial sections along the anterior–posterior axis of stage 32/34 embryos subjected to varying amounts of
AGN 194301. A complete tube with distinct left–right asymmetry was clearly evident throughout most of the control myocardial domain (first column, A, E, I, M, Q
with anterior at the top and posterior at the bottom). Consistent with the whole-mount data, no evidence of linear heart tube formation was detected in 1 μM AGN
194301 treatments (second column, B, F, J, N, R), while a partial, relatively symmetrical heart tube could be detected within 100-nM-treated embryos (third column,
C, G, K, O, S). Formation of a heart tube was observed in embryos subjected to 10 nM AGN 194301 (fourth column, D, H, L, P, T), although the fusion was not as
extensive as seen in control embryos. In addition, at this stage, the left and right side appeared symmetric when compared to control embryos.
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with RA. In normal stage 30/32 embryos, Nkx2.5 is strongly
expressed in the newly formed linear heart tube and in the
overlying mesocardium and pericardium (Raffin et al., 2000).
Treatment with 1 μM all-trans RA at the end of gastrulation
(stage 12) resulted in severe inhibition of Nkx2.5 expression
(Figs. 5E, F), and the staining was restricted to the anteriorend of the heart tube. In a minority of cases, Nkx2.5 expres-
sion was completely abolished.
RA antagonism with 1 μM AGN 194301 at stage 14 did not
result in an expansion of the Nkx2.5 expression domain. In-
stead, a moderate restriction of the Nkx2.5 expression domain
was noted, although the expression was expanded dorsally in
these embryos. The spur-shaped dorsal expansion was variable
Fig. 3. Common morphologies of differentiated hearts from embryos treated with retinoic acid antagonists. When viewed from the ventral side, control embryos
stained for αMHC expression by whole-mount in situ hybridization show a heart tube that is initiating the normal looping process (A). The most severe phenotype
observed with AGN 194301 treatment was a lack of both tube formation and a ventral gap in the αMHC expression domain indicating a lack of fusion of the two heart
primordia (B). Embryos that showed a fusion of the heart primordia at the ventral midline but still no tube formation (C) were seen with lower doses of antagonist. At
even lower doses of antagonist, the most common heart phenotype observed was an apparent heart tube that appeared to not undergo looping at this stage (D).
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close proximity to the presumptive kidney (Figs. 5I, J). When
antagonist-treated embryos were viewed from the ventral side,
Nkx2.5 expression was in a ventral sheet as shown for cTnI.
Addition of equal amounts of both AGN 194301 and RA
resulted in a rescue of phenotype observed for either individual
treatment (Figs. 5M, N).
During heart formation, GATA-4 is broadly expressed in the
heart and upper gut region, overlapping with much of the
Nkx2.5 expression (Figs. 5C, D). Treatment with 1 μM all-
trans RA appeared to slightly expand the expression domain
of GATA-4 and shifted the expression domain to a more anterior
position beneath the cement gland (Figs. 5C, D), although it
must be noted that the small changes in the head morphology
that are also observed may have caused the shift in expression
pattern.
The treatment with 1 μM AGN 194301 at stage 12/14
resulted in an inhibition but not elimination of GATA-4 ex-Table 1
Types of disruptions in cardiac morphology seen in varying concentrations of
AGN 194301 (RAA)
Treatment (n) Normal
heart tube
Ventral gap Ventral
sheet
Symmetrical
tube
1 μl/ml DMSO (22) 100 0 0 0
1 μM RAA (22) 0 45 55 0
500 nM RAA (20) 10 0 50 40
100 nM RAA (24) 8 0 34 58
50 nM RAA (28) 7 0 20 73
10 nM RAA (24) 33 0 17 50
1 μM RAA and RA (24) 92 0 0 8
Values are expressed as percentages of total embryos examined.pression. The cells that do express GATA-4 are restricted to
posterior and ventral position in the presumptive heart tube
(Figs. 5K, L). The cells expressing GATA-4 form an unfolded
sheet at the time control embryos or RA-treated embryos have
a heart tube. The phenotype seen when treated with the
antagonist was rescued by addition of an equimolar concen-
tration of RA (Figs. 5O, P).
Recently, similar experiments in zebrafish have shown that
RA signaling can restrict the number of cardiac progenitors
(Keegan et al., 2005), thus it remained possible that RA was
also influencing heart tube formation and Nkx2.5 expression
earlier than stage 14. To investigate this possibility, embryos
were exposed to 1 μM AGN 194301 before gastrulation
(stage 6). As observed in zebrafish, early treatment with RA
antagonists appeared to increase the expression domain of
Nkx2.5 (Fig. 6), when assayed before heart tube formation,
although the increase was modest compared to the changes
seen in zebrafish. However, if allowed to develop further, the
expanded Nkx2.5 domain was not sustained, and, by stage 32,Table 2
Blocking retinoic acid signaling does not result in precocious expression of cTnI
Stage Control RAA-treated
24 0/34 0/45
25 0/70 0/48
26 7/52 3/52
27 27/48 9/49
28 32/36 9/24
The numbers represent the number of embryos with cTnI expression as detected
by whole-mount in situ hybridization over the total number of embryos exam-
ined for cTnI expression at that stage.
Fig. 4. Blocking RA signaling is required in a narrow window of time for formation of the heart tube. The heart has been visualized by whole-mount in situ
hybridization for cTnI and is viewed in whole cleared embryos in side view (top panel) and from the anterior end (bottom panel) in order to visualize the formation of
a tube. Normal heart tube formation can be seen in stage 31/32 embryos that were treated with 2 μl/ml DMSO as a carrier control (A, G). Treatment with 1 μM RA at
stage 14 resulted in a dramatic decrease of myocardial differentiation (B, H). Treatment with 1 μMAGN 194301 resulted in a block to heart tube formation remained
as a sheet along the ventral midline (C, I). cTnI expression levels and spatial distribution were restored if RA and AGN 194301 were given in equimolar amounts
(D, J). When embryos were subjected to an initial treatment of 1 μM AGN 194301 at stage 14 with subsequent addition of 1 μM RA at stage 16, cTnI expression
(E, K) was also similar to control patterns. However, when the addition of RA was delayed until stage 18/20, cardiomyocyte differentiation was shown to be again
restricted to posterior regions of the normal heart field and linear heart tube formation was not detected (F, L). Thus, blocking RA signaling in a tight window of
time between stages 14 and 18 is sufficient to prevent formation of the heart tube.
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where RA antagonism was initiated at stage 14. This was not
simply a loss of Nkx2.5 expression as the expression of cTnI
was also markedly reduced (Figs. 6E, F). In zebrafish, expres-
sion of eHAND was used as general marker of lateral plate
mesoderm, and the lack of RA signaling did not alter this
expression domain, indicating that the overall size of the
lateral plate mesoderm was not altered by RA antagonism.
In zebrafish, there only appears to be one HAND gene (Yelon
et al., 2000), and, in Xenopus, the expression of HAND1
(eHAND) appears to most closely resemble the zebrafish
pattern (Angelo et al., 2000). To further test for species-
specific differences, we examined the expression HAND1 in
embryos treated with AGN 194109. The HAND1 domain was
smaller and appeared truncated at the anterior and posterior
end in embryos treated with AGN 194109 (Figs. 6C, D).
Late stage consequences of altered heart morphology
Despite the vastly different morphologies of the RA and
antagonist-treated embryos, the majority of embryos still
formed beating tissue. When compared to normal hearts (Fig.
7A), RA-treated hearts (Fig. 7C) at stage 45 appeared smaller.
There was a small but significant reduction in heart rate in these
embryos. This small difference in heart rate was confirmed
using AGN 193836, an RARα agonist (Fig. 7D), which again
showed a small but significant drop in heart rate (Fig. 7E).
Blood was seen moving through the vasculature of both RA
and agonist-treated embryos, indicating that a competent car-
diovascular network had been formed.
Treatment with 1 μM AGN 194301 resulted in a slow
beating nub. The nub can be seen within a large cavity,which has formed below the head in the ventral half of the
embryo (Fig. 7B). The nub might have been mistaken for
neighboring gut tissue, except for its ability to contract. Pool-
ing of red blood cells in the gut cavity was also observed
indicating that the heart never formed a closed tube. Heart rate
in these embryos was much lower than in either RA-treated or
control embryos, essentially halved as a result of antagonist
treatment (Fig. 7E).
Blocking RA signaling caused a failure to form a competent
cardiovascular network. To determine if this was due to the lack
of heart tube closure being permanent, we examined cardiac
morphology at later stages of development. The resolution
needed to examine this question was provided by whole-
mount immunocytochemistry followed by imaging with a con-
focal microscope. We examined control and treated embryos
that were allowed to develop until the control embryos were at
stage 39. Two antibodies were used to stain the heart, anti-
cardiac troponin I, and the monoclonal antibody F-22 which
stains the extracellular matrix protein flectin. Flectin is an ex-
tracellular matrix protein found in the developing heart and is
expressed in an asymmetrical manner (Linask et al., 2002;
Tsuda et al., 1996; Kolker andWeeks, unpublished).We observe
flectin in the matrix between the endocardium and myocardium
as well as around the vasculature. One characteristic of myocar-
dial development is the change in myocardial cell shape during
cardiogenesis, from cells that have a distinctive columnar ap-
pearance to cells with a more compacted morphology. This
progression can be seen in Figs. 8A–C. Secondly, myocardial
production of flectin has a distinctive temporal progression,
with staining first appearing intercellular and near the surface
of the myocardium (compare Figs. 8B and C). When embryos
were treated with 1 μM AGN 194301, the morphology of the
Fig. 5. Treatment with retinoic acid antagonist alters the expression domains of Nkx2.5 and GATA-4. The expression domains of Nkx2.5 and GATA-4 are visualized by
whole-mount in situ hybridization. In control embryos treated with 2 μl/ml DMSO (top panel, A–D), the normal expression domain of Nkx2.5 and GATA-4 can be
seen in side view and viewed from the ventral side. Treatment with 1 μM RA caused a severe reduction in the expression pattern of Nkx2.5 (E, F) but did not cause
any obvious change in the expression pattern of GATA-4 (G, H). Treatment with 1 μMAGN 194301 caused a marked change in the expression domain of Nkx2.5. As
expected, the expression domain was restricted to a sheet of cells rather than a tube, and the expression was restricted to the posterior end of the region that normally
expresses cTnI (I, J). In addition, there was a marked spur of Nkx2.5 expression that extended dorsally close to the level of the somites (red arrow). Treatment with
AGN 194301 caused a reduction, but not elimination of the GATA-4 expression domain (K, L). If embryos were simultaneously exposed to 1 μMRA and 1 μMAGN
194301, the expression domains of Nkx2.5 and GATA-4 were similar to controls (M–P).
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to cells of a control embryo at stage 31 (Fig. 8A) rather than the
compact shape found in control stage 39 embryos (Fig. 8C). The
non-fused lateral fields are readily visible as is the failure to
form a tube, so these two features of AGN 194301 treatment
have not recovered with time, however, at the later stages, the
fields are not strictly a flat sheets of cells. A pouch forms from
the sheet. This out-pouching occurs even if the heart forms two
separate sheets of myocardial tissue that do not meet at the
midline (Fig. 8D).
Even though the myocardium looks immature, it still
seems able to carry out the temporally correct synthesis offlectin and transport the flectin out of the cell. Thus, the
flectin staining in AGN-194301-treated embryos suggests
that the myocardium was able to complete part of the cardiac
molecular program even when unable to form a closed heart
tube (Fig. 8).
The hearts of AGN-194301-treated embryos at stage 30/32
(Fig. 3) appeared symmetrical when observed using whole-
mount in situ hybridization. This was not a surprise as dis-
ruption in left–right patterning by blocking retinoid signaling
has been described in other animal models (Chazaud et al.,
1999; Niederreither et al., 2001; Wasiak and Lohnes, 1999).
However, left–right patterning, including looping, is a multi-
Fig. 6. Treatment of embryos with antagonist prior to gastrulation alters
patterning of cardiac genes. At embryonic stage 20, Nkx2.5 is normally
expressed in a broad sheet on either side of the cement gland (A). When
embryos were treated with AGN 194301 prior to gastrulation (stage 6), this
domain appeared expanded, particularly along the anterior–posterior axis (B).
When compared to expression in control embryos (C), the expression of the
lateral plate mesoderm marker, HAND1, was diminished by the same treat-
ment (D) with shortening both from the posterior and anterior end of the
embryo (anterior is left and posterior is right in both C and D). Despite the
early changes in Nkx2.5 expression, the myocardium still failed to form a tube
and the Nkx2.5 (E) and cTnI (F) expression domain was reduced with
essentially the same phenotype as observed in embryos treated with RA
antagonists post-gastrulation (see Fig. 1).
Fig. 7. Altering retinoic acid signaling has profound affects on the final mor-
phology of the cardiovascular system. A normally developed was seen in stage 41
control embryos (A). Treatment with AGN 194301 resulted in a small contractile
nub (B). Treatment with RA resulted in a smaller then normal contracting heart
(C). Treatment with an agonist to RA results in a phenotypic heart similar to that
produced by RA treatment (D). All hearts were outlined, in a relaxed phase, to
better visualize heart size. (E) Altering RA signaling during early heart develop-
ment results in a decreased heart rate in stage 41 embryos (n = 20, P ≤ 0.01).
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bending of the cardiac tube were not seen, we have looked
at AGN-194301-treated embryos for earlier indications that
left–right patterning was still established. Confocal analysis of
treated embryos suggests that at least early features of left–
right patterning still occurred (Fig. 9). In normal hearts, at
stage 33/34, distinct changes can be seen in the movements of
heart looping. In particular, there is an inflexion on the right
side that is at the anterior end of the heart tube, while an
inflexion on the left side is at the posterior end. In embryos
treated with AGN 194301, although no tube forms, the char-
acteristic differences in inflexion points still occur, albeit at
later stages of development. This implies that aspects of the
left–right information may still be in place and also that some
of the movements of looping can still occur despite not
forming a tube.Discussion
Xenopus embryos treated with RA have severe disruptions in
cardiac development (Drysdale et al., 1994, 1997; Jiang et al.,
1999). Those results do not imply a normal function for RA in
Xenopus cardiogenesis. This study demonstrates that there is a
specific requirement for RA signaling in Xenopus cardiogenesis,
consistent with observations in both avian and mammalian sys-
tems, where endogenous RA signaling has been attenuated either
by dietary restriction, knockouts of specific elements of the RA
signaling pathway, or by use of RA antagonists (Chazaud et al.,
1999; Hochgreb et al., 2003; Iulianella and Lohnes, 2002; Kee-
gan et al., 2005; Kostetskii et al., 1999; Liberatore et al., 2000;
Rosenthal and Xavier-Neto, 2000; Yutzey et al., 1995; Zile et al.,
2000). Here, we describe the requirements for RA signaling in
Xenopus cardiogenesis and demonstrate that different activities
are observed depending on the precise stage of embryogenesis.
Initial roles for retinoic acid in heart development
The heart is derived from anterior lateral plate mesoderm.
In zebrafish, the initial events in cardiogenesis are influenced
Fig. 8. Cardiomyocytes retain an immature appearance after AGN 194301
treatment. Control embryos at stage 31 (A), stage 35 (B), stage 39 (C), and an
AGN-194301-treated embryo (D) fixed at the same time as control sibling
shown in C were immunolabeled and analyzed by confocal microscopy (10
RA antagonist embryos were analyzed; this embryo represents the trend seen).
The black and white inset represents a compilation of all the optical sections of a
z-series (60–70 4 μm sections) taken through the embryos as viewed with the
muscle marker cardiac troponin I. The colored micrograph represents an optical
thick section that is a subset of the inset (10 consecutive sections). Red = cardiac
troponin I; green = F-22, flectin. The normal stage 31 embryo (A) shows the
heart region after the left and right fields have fused but prior to tube closure.
The troponin I staining reveals large columnar muscle cells characteristic of the
stage. There is some flectin staining apparent on the basal side of the mesoderm
as well as faint intracellular staining in the muscle cells of the left heart field in
this particular subset of sections. At stage 35 (B), the heart has fused to form a
tube and is beginning to undergo S-shaped looping. The muscle cells have lost
their columnar appearance, and muscle striations are visible. Flectin is distrib-
uted in a subset of muscle cells as well as both the basal and apical surface of
the endocardium. The normal stage 39 embryo heart (C) is viewed just prior to
trabeculation; the striations more evident. The majority of the flectin staining is
seen in the ECM. The 1 μM AGN-194301-treated embryos have unfused heart
fields. They have not formed tubes but as they develop do not remain as flat
sheets. The muscle cells have the columnar appearance of a less mature stage 31
embryo. The flectin staining has a temporal characteristic more similar to stage
39 with the majority of the localization in the ECM.
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within the lateral plate mesoderm (Keegan et al., 2005). A
similar process occurs in Xenopus because, when RA signal-
ing is blocked prior to gastrulation, the early Nkx2.5 expres-
sion domain appears enlarged although not to the same extent
as that observed in zebrafish. However, the ratio of Nkx2.5-
expressing cells to HAND1-expressing cells is markedly in-
creased (Fig. 6) because of the observed decline of the
HAND1 expression domain. The enlarged Nkx2.5 expression
domain could be indicative of the general increase in anterior
structures observed when RA signaling is blocked prior to
gastrulation in Xenopus (Koide et al., 2001). Alternatively, the
changes in Nkx2.5 and HAND1 expression may indicate a
more general role for RA in patterning the lateral plate
mesoderm.The inability of the early antagonist treatment to generate a
larger differentiated heart is clearly different than what is ob-
served in zebrafish where the cardiac myosin light chain 2
expression closely mirrors the Nkx2.5 expression. At the time
of cardiac differentiation, both the Nkx2.5 expression domain
and the expression of cTnI are much smaller than normal in
Xenopus. Perhaps the additional cells expressing Nkx2.5 lack
another factor required for maintenance of Nkx2.5 expression or
the additional Nkx2.5 expression is insufficient to cause the
cells to change their fates. Our observation that GATA-4 and
Nkx2.5 behave differently to alterations in RA signaling (Fig. 5)
and that differentiation is only apparent where both are co-
expressed would support this concept. Addition of exogenous
RA results in expression of cTnI only in the anterior half of the
heart-forming region, where Nkx2.5 and GATA-4 are co-
expressed (compare Figs. 1 and 4). When embryos are treated
with the AGN 194301, the observed dorsal spur of Nkx2.5
expression reaches close to the developing somites (Fig. 4)
but does not result in an expansion of cTnI expression. In
these embryos, the GATA-4 expression domain is restricted,
although not eliminated (Fig. 4), as has been observed in
RALDH2 −/− mice (Niederreither et al., 2001) and in the
quail dietary deficient model (Kostetskii et al., 1999). In these
embryos, as well as control embryos, the overlap between the
Nkx 2.5 and GATA-4 expression domains best predicts where
cTnI will be expressed.
Retinoic acid signaling is required for rolling up of the heart
tube
The most obvious defect observed in embryos where RA
signaling was attenuated is the permanent lack of heart tube
closure. Rolling up of the heart tube requires RA signaling
between embryonic stage 14 and 18, well before the actual
morphogenetic event (Fig. 4). A failure to transition from a
sheet of cells to a heart tube has not been observed in other
models of RA deficiency. This could imply an RA-sensitive
event that is unique to Xenopus, although when comparable
antagonist treatments have been done in chick, a widening of
the myocardium can be seen, perhaps indicating a similar
phenotype although tube closure was not directly assessed
(Hochgreb et al., 2003). The mechanisms for transiting from a
single fused heart primordium to a tube do appear to vary
between model organisms. Zebrafish forms a cone structure
(Glickman and Yelon, 2002), and mammals form both endo-
cardial and myocardial tubes before fusion. These differences
in cardiac morphogenesis may indicate unique molecular or
morphogenetic events.
Alternatively, although the lack of tube formation in Xeno-
pus appears novel, it may share common features with other
RA deficiency experiments by representing a disruption in
the normal timing of cardiac events. In both RALDH2 and
RAR knockout mice, premature differentiation of the myocar-
dium is observed (Kastner et al., 1997; Niederreither et al.,
1999). A plausible explanation of the failure to form a tube
in Xenopus is that it represents a failure to progress through
normal stages of morphogenesis, although precocious cardiac
Fig. 9. Elements of the normal looping process are evident in the non-tubular hearts of RA-antagonist-treated embryos. Normal stage 33 embryos and RA-
antagonist-treated embryos were fixed, immunolabeled with cardiac troponin I, imaged by confocal microscopy, and analyzed. Consistent characteristics among
the groups were noted and are represented in the images of the individuals shown. Images A–D are a series of optical “thick sections”(ventral view) taken
through a stage 33 normal Xenopus embryo (the inset in A is a compilation of the entire series). The series is presented in a ventral to dorsal progression as
depicted in schematic I. At stage 33, the Xenopus heart field is just beginning tube closure (D), yet elements of looping have begun. (1) There is a ventral
bulging of the heart field issue (evident by ventral–dorsal series A–D or I). (2) The asymmetric nature of the heart becomes more evident as it bends to form a
“c-shaped” structure, curved to the embryos right (B, C). (3) The forming tube also rotates, positioning the original left heart field (pseudo-colored blue in series
A–D, J) more ventrally and the original right heart field (pseudo colored yellow) more dorsally. These changes are illustrated in panels A–D with A, the most
ventral sections, showing mainly left field (blue) progressing to D, the most dorsal sections, showing tissue only from the right field (yellow). The undeveloped
future sino-atrial region remains evenly distributed across the right–left axis of the embryo, however, the right side is becoming more anterior than the left. In
all species, the looping heart forms a series of complementary curves. For example, the outer portion of the “c shaped” curvature on the right side of the heart
can be matched to the inner part of the “c-shaped” curve on the left side of the heart. The complementary curves are highlighted green and red on many of the
panels and shown separately in panels K and L. Panels E–H (schematic J) are a ventral–dorsal series of the heart region of a 1 μM 194301-treated embryo
fixed when untreated littermates reached stage 39. Inset E shows the entire z-series through the heart field compiled. Confocal imaging the myocardium of these
embryos revealed that many characteristics of looping are present. (1) The heart fields of the RA-antagonist-treated embryos did not remain flat sheets. Although
the most posterior (the would-be sino-atrial region of an earlier normal embryo) remained evenly distributed among the ventral–dorsal, the right–left, and the
anterior–posterior axes (E, F), (2) anterior to this region, the left field (blue) assumed a ventral position (note presence in E, lack thereof in H) while the right
field (yellow) assumed a more dorsal prominence (present in H and not E). (3) Additionally, the left and right fields make the appropriate “c-shaped” bends with
respect to the embryo's midline (G, H). The most prominent left side curvature of F and the most prominent right side curvature of H are copy/pasted into
cartoon L. By digitally swinging the bottom (anatomical posterior end) of the curved lines toward the anatomical midline, the complementary pair resembles the
pattern of a stage 33 heart (L and K).
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ogies in antagonist-treated embryos range from failing to
progress beyond a split ventral–lateral sheet of cells when
exposed to high levels of antagonist to a heart tube that fails
to execute the looping program when exposed to low levels
of antagonist (Fig. 3). This range of defects can be viewed as
snapshots of different steps along the morphogenetic pathway
in normal Xenopus hearts (Kolker et al., 2000; Mohun et al.,
2000). Supporting this concept is that the higher the dose of
antagonist, the hearts appear to be stopped at earlier stages of
morphogenesis (Fig. 7). In antagonist-treated embryos, indi-
vidual cardiomyocytes also have an immature morphology
(Fig. 7). A role for RA in controlling timing has been
observed in the establishment of the segmentation clock in
somites (Moreno and Kintner, 2004), the temporal control of
transcription in the nervous system (Diez del Corral et al.,
2003; Novitch et al., 2003) and in the limb bud (Mercader et
al., 2000).Patterning changes in the heart due to changes in RA signaling
In both chick and mouse, a model of heart tube patterning
has been proposed that gives RA a role in specifying sino-
atrial structures and that the source of RA is determined by
the dynamic expression of RALDH2 in the posterior and
lateral plate mesoderm (Hochgreb et al., 2003; Xavier-Neto
et al., 1999, 2000, 2001). When Xenopus embryos are treated
with RA or RA antagonist, the position of the differentiated
myocardium is altered along the anterior–posterior of the
embryo. If differentiated myocardial tissue is seen in RA-
treated embryos, the cTnI expressing region is at the anterior
end of presumptive heart region (Fig. 1). However, we can-
not conclude that anterior–posterior information has been
altered within the developing myocardium. Examination of
Tbx5 and Irx4 expression (Garriock et al., 2001; Horb and
Thomsen, 1999), which could address this issue, was incon-
clusive as expression of both markers was very low in both
107A.H. Collop et al. / Developmental Biology 291 (2006) 96–109RA-treated and AGN-194301-treated embryos (data not
shown).
RA signaling has been implicated in the formation of the
left–right axis in several model systems, and abnormal heart
looping is a consequence (Chazaud et al., 1999; Iulianella and
Lohnes, 2002; Kawakami et al., 2005; Niederreither et al.,
2001; Tanaka et al., 2005; Tsukui et al., 1999; Vermot et al.,
2005; Wasiak and Lohnes, 1999). When we examined the
cardiac morphology of AGN-194301-treated embryos at stage
32/34, the hearts appeared symmetrical (Fig. 2). However,
when later stage embryos were examined using confocal mi-
croscopy, inflexions were observed in hearts that had even
failed to fuse at the midline, indicating that at least some
aspects of left–right asymmetry were still established even in
these grossly abnormal hearts (Fig. 9).
In chick, flectin is asymmetrically expressed and is de-
creased and disorganized in quail embryos that lack RA due
to dietary insufficiency (Linask et al., 2002; Tsuda et al., 1996).
Although we see similar asymmetry in flectin expression dur-
ing normal Xenopus heart development (Kolker, Dagle, and
Weeks, in preparation), unlike the dietary restriction studies
carried out in quail, we observe significant flectin expression
in the AGN-194301-treated embryos (Fig. 8). We also observe
that, even in the absence of full heart tube formation, some of
the distinctive left–right axis changes are maintained (Fig. 9).
This suggests that the early identification of sidedness is not
lost when RA signaling is inhibited after gastrulation, but the
completion of looping program is encumbered. The loss of
laterality in dietary deficiency models is correlated with a loss
of Pitx2 and nodal expression, but not the expression of earlier
genes that establish the left–right axis such as activin receptor
IIa, sonic hedgehog, caronte, Lefty-1, and fgf-8 (Romeih et al.,
2003; Zile et al., 2000). Mice that express a dominant negative
RARγ2 allele exhibit predominantly normal situs but have
aberrant looping morphogenesis (Iulianella and Lohnes,
2002). In RALDH2 −/− mice that have severely reduced levels
of RA, there is also normal situs, but the heart is also impaired
in its ability to loop (Niederreither et al., 2001). Together, these
results point to a conserved role for retinoid signaling in the
progress of cardiac morphogenesis or maintenance of a left–
right pattern rather than a direct role in establishing left–right
asymmetry. Some aspects of this model contradict results
obtained using RA antagonists in mouse at the head fold
stage where left–right asymmetry is blocked (Chazaud et al.,
1999; Tsukui et al., 1999).
Consequences of blocking RA signaling for later cardiac
development and physiology
RA-treated embryos develop an intact circulatory system as
circulating blood could be observed, indicating that a heart tube
does form and develop connections to the vascular system.
Although a nub of beating tissue could be observed in the
antagonist-treated embryos (Fig. 3B), there was a lack of cir-
culating blood as would be predicted their cardiac morphology
(Fig. 8). The reduction in size, position of the nub, and the lack
of circulating blood were very similar to hearts seen in Xenopusembryos where Tbx5 activity is disrupted (Horb and Thomsen,
1999). This suggests that RA signaling and Tbx5 activity may
be affecting common downstream events.
Interestingly, the nub had a heart rate that was reduced to
about 50% of normal (Fig. 4). This is essentially the same as
heart rate reductions seen in dietary deficiency models (Heine et
al., 1985). It is unclear as to whether this difference in beating
frequency is due to alterations in cardiac morphology or due to a
direct effect on elements of the conduction system that are
known to be sensitive to RA signaling (van Veen et al., 2002).
Taken together, these results demonstrate that RA signaling
during a relatively narrow window of time is important for
multiple aspects of cardiac development in Xenopus. Although
the lack of heart tube formation is not observed in other model
organisms, a common role for RA in controlling timing and
differentiation in cardiogenesis may underlie the observed
phenotype.
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